Regulatory oversight of clinical trials in Africa: progress over the past 5 years.
Randomized controlled clinical trials represent the best way to establish the therapeutic or preventive value of medicines. This decade has seen a strong shift in the location of clinical trials from industrialized countries to developing countries, including many in Africa. However, without independent strong regulatory and ethical oversight of clinical trials the safety of research subjects, and scientific integrity of clinical data cannot be verified. This article draws up a portrait of clinical trials regulation in Africa in support of development of priority medicines, highlights challenges and presents the progress made by countries under WHO guidance over the past 5 years.
Maïga
Diadié
D
Quality Safety and Standards, Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
Akanmori
Bartholomew Dicky
BD
Chocarro
Liliana
L
D000349:Africa; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D035842:Research Subjects; D014612:Vaccines / Q000592:standards; D014944:World Health Organization
D014612:Vaccines